SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-001062
Filing Date
2018-02-05
Accepted
2018-02-05 09:05:42
Documents
5
Period of Report
2018-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 31857
2 AMENDMENT 2 TO COLLABORATIVE RESEARCH AGREEMENT ndra_ex101.htm EX-10.1 16342
3 PRESS RELEASE ndra_ex991.htm EX-99.1 18745
4 IMAGE ndra_ex101000.jpg GRAPHIC 1482
5 IMAGE ndra_ex991000.jpg GRAPHIC 3968
  Complete submission text file 0001654954-18-001062.txt   76018
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 18572912
SIC: 3845 Electromedical & Electrotherapeutic Apparatus